Osborne Clarke in Amsterdam has advised lead investors on Northsea Therapeutics' USD 80 million Series C financing round
Osborne Clarke in Amsterdam has advised lead investors Ysios Capital and Forbion Growth on Northsea Therapeutics' USD 80 million Series...
Published on
20/12/2021
Read time
1m